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Methylation of nonhistone proteins is emerging as a
regulatory mechanism to control protein function.
Set7 (Setd7) is a SET-domain-containing lysine
methyltransferase that methylates and alters func-
tion of a variety of proteins in vitro, but the in vivo
relevance has not been established. We found that
Set7 is a modifier of the Hippo pathway. Mice that
lack Set7 have a larger progenitor compartment in
the intestine, coinciding with increased expression
of Yes-associated protein (Yap) target genes. Mech-
anistically, monomethylation of lysine 494 of Yap
is critical for cytoplasmic retention. These results
identify a methylation-dependent checkpoint in the
Hippo pathway.
INTRODUCTION
The site-specific methylation of histone lysine residues by lysine
methyltransferases (KMTs) has been shown to regulate gene
expression by modulating chromatin structure to either repress
or activate genes at specific loci (Jenuwein and Allis, 2001).
More recently, lysine methylation of nonhistone proteins has
emerged as a novel regulatory mechanism to control protein
function, primarily by affecting stability (Este`ve et al., 2009;
Huang and Berger, 2008; Su and Tarakhovsky, 2006). However,
the in vivo relevance of this posttranslational modification
remains unknown.
Set7 is a KMT that was initially identified as a monomethylase
of histone H3 lysine 4 (H3K4) in vitro (Wang et al., 2001). How-
ever, because Set7 is unable to methylate nucleosomes at
H3K4 (Chuikov et al., 2004) and Setd7/ mouse embryonic188 Developmental Cell 26, 188–194, July 29, 2013 ª2013 Elsevier Infibroblasts (MEFs) have normal levels of H3K4 methylation
(Lehnertz et al., 2011), it is more likely that the primary role for
Set7 is methylation of nonhistone substrates (Pradhan et al.,
2009). Indeed, Set7 has been shown to methylate and alter
function of a wide variety of proteins including Dnmt1, Taf10,
p53, Stat3, and NF-kB in vitro (Chuikov et al., 2004; Ea and
Baltimore, 2009; Este`ve et al., 2009; Kouskouti et al., 2004;
Kurash et al., 2008; Yang et al., 2009, 2010a, 2010b). However,
the in vivo relevance of Set7-dependent methylation has not
been established. In fact, a role for Set7 in alteration of p53
function in vivo has recently been refuted (Campaner et al.,
2011; Lehnertz et al., 2011), which is in agreement with a study
demonstrating that mutation of the lysine residues potentially
methylated by Set7 in p53 did not dramatically alter its function
(Krummel et al., 2005). Thus, the physiological role for Set7
remains unknown.
The Hippo pathway is an evolutionarily conserved signaling
pathway that regulates organ size and function (Cai et al.,
2010; Camargo et al., 2007; Dong et al., 2007; Heallen et al.,
2011; Schlegelmilch et al., 2011). Canonical activation of the
Hippo pathway is initiated by cell-cell contact, cell polarity,
and mechanical cues, which through a kinase cascade ulti-
mately leads to the phosphorylation and subsequent cytosolic
sequestration and/or degradation of the Hippo pathway trans-
ducers Yes-associated protein (Yap) and transcriptional coacti-
vator with PDZ binding motif (Taz) (Kanai et al., 2000). Yap/
Taz function as transcriptional coactivators of proliferation and
antiapoptosis genes by interacting with transcription factors in-
cluding the canonical Drosophila Scalloped homologs Tead1/4
(Zhao et al., 2008). As dysregulation of Yap/Taz is associated
with several types of cancer such as breast, liver, and colon
(Cordenonsi et al., 2011; Pan, 2010; Zhou et al., 2011), a better
understanding of the molecular pathways controlling the Hippo
pathway will be critical in the development of novel Hippo
pathway-specific therapeutics. Using cells and mice geneticallyc.
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Figure 1. IEC-Intrinsic Expression of Set7
Controls Intestinal Homeostasis
(A) Setd7f/f (black bars) and Setd7DIEC (gray bars)
IECs and mesenteric lymph nodes (mLN) were
isolated from Setd7f/f and Setd7DIEC mice. Setd7
expression, relative to that in Setd7f/f mice, was
assessed by qPCR.
(B) H&E stained section of cecal tissue. Bar, 25 mm.
(C) Quantification of crypt width and length
(50 crypts per mouse, five mice per group).
(D) Representative cecal section stained for EdU
and DAPI. Frequency of EdU-positive cells per
crypt is shown in graph (40 crypts per mouse from
five mice).
(E) Expression of indicated genes in IECs isolated
from naive Setd7f/f and Setd7DIEC mice was
determined by qPCR. Expression is relative to
Setd7f/f IECs using actin as housekeeping gene.
(F) Cecal sections were analyzed by immunofluo-
rescent staining for Yap. The number of nuclei per
crypt that exhibitedcharacteristic specklednuclear
localization of Yap is shown (50 crypts per mouse
from five mice per group). Data are presented as
mean ± SEM (n = 5–10 mice per genotype).
au, arbitrary units. *p < 0.05. See also Figure S1.
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Yap Function Is Regulated by Lysine Methylationdeficient in Set7, we demonstrate that Set7 is a central compo-
nent of the Hippo pathway through the regulation of Yap
localization. We show that Yap and Set7 interact, that Yap is
monomethylated at K494, and that a mutated Yap (YapK494R)
is not cytoplasmically retained. Taken together, our results
identify a methylation-dependent checkpoint in the Hippo
pathway that may act as a therapeutic target to modulate this
pathway.
RESULTS AND DISCUSSION
To directly assess the cell autonomous role of Set7 in vivo, we
generated intestinal epithelial cell (IEC)-specific Set7-deficient
mice (Setd7DIEC mice) by crossing mice in which exon 2 was
flanked with loxP sites (Setd7f/f mice) with mice expressing the
Cre recombinase under the control of the IEC-specific Villin pro-
moter (el Marjou et al., 2004; Lehnertz et al., 2011). Setd7DIEC
mice lack Setd7 expression specifically in IECs (Figure 1A) and
display no overt phenotypes. However, examination of the intes-
tines of Setd7DIEC mice revealed differences in the intestinal
architecture compared to that of control Setd7f/f mice. Intestinal
crypts from Setd7DIEC mice were shorter and wider than those of
Setd7f/f mice (Figures 1B and 1C). We also observed an
increased frequency of proliferating cells per crypt in Setd7DIEC
mice (Figure 1D), as measured by examining cellular uptake of
EdU 2 hr following injection. IEC proliferation and differentiation
are tightly regulated processes controlled by the Wnt, Notch,
and Hippo signaling pathways (Cai et al., 2010; Camargo et al.,
2007; van der Flier and Clevers, 2009). We isolated IECs from
colons of naive Setd7f/f and Setd7DIEC mice and measured
gene expression of direct and indirect target genes of the
different pathways. Wnt (Lgr5 and Sox9) and Notch (Hes1 and
Math1) target genes were not differentially expressed in IECs
isolated from naive Setd7DIEC mice compared to Setd7f/f mice
(Figure 1E). In contrast, Hippo pathway-associated genes Ctgf
and Gli2 were expressed at significantly higher levels in IECsDeveisolated from Setd7DIEC mice (Figure 1E), suggesting a cell-
intrinsic role for Set7 in regulating Hippo pathway-associated
genes.
In wild-type mice, protein expression of the Hippo transducer
Yap is only observed in the nuclei of cells at the base of the
intestinal crypt and is associated with intestinal stem cells and
transit-amplifying progenitor cells (Cai et al., 2010; Camargo
et al., 2007). Consistent with increased expression of Yap target
genes in IECs from Setd7DIEC mice, we observed significantly
increased numbers of Yap-positive nuclei per crypt in Setd7DIEC
mice compared to Setd7f/f mice, with differences being most
notable in the upper half of the crypt (Figure 1F; Figure S1 avail-
able online). From these data, we conclude that IEC-intrinsic
expression of Set7 is required to regulate the size of the prolifer-
ative progenitor compartment, potentially through regulation
of the Hippo pathway. Of note, a previous study has shown
that mice with an IEC-intrinsic deletion of the upstream Hippo
pathway adaptor protein Salvador1/WW45 (Sav1) also hadwider
and shorter crypts with more proliferative progenitors (Cai et al.,
2010).
To directly test whether Set7 was directly involved in regula-
tion of the Hippo pathway, we studied the well-described
Hippo-pathway-dependent process, cell-cell contact-mediated
growth inhibition (Zhao et al., 2007). We used immortalized
MEFs derived from Setd7/ and Setd7+/+ mice (Lehnertz
et al., 2011). Although no difference in proliferation was detected
in the first 48 hr after seeding, once cells reached confluence,
Setd7/ MEFs were less susceptible to contact inhibition of
proliferation than Setd7+/+ MEFs as indicated by increasing cell
number over time (Figure 2A). Although we failed to detect any
differences in expression of the canonical Yap target genes
Ctgf and Cdc20 in low-density Setd7+/+ or Setd7/ MEFs, we
observed significantly increased expression of Ctgf and Cdc20
in high-density Setd7/ MEFs compared to Setd7+/+ MEFs
(Figure 2B). Furthermore, Setd7 expression was not affected
by cell density and Yap expression was similar in Setd7+/+ orlopmental Cell 26, 188–194, July 29, 2013 ª2013 Elsevier Inc. 189
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Figure 2. Set7 Regulates Cell-Cell Contact-
Mediated Growth Inhibition, and Set7
Methyltransferase Activity Is Required for
Yap Localization and Function
(A) Setd7+/+ (closed circles) and Setd7/ (open
circles) MEFs were plated at 23 105 cells per well,
and cell numbers were counted at various time
points after plating.
(B) Expression of Yap-dependent genes in low-
density (LD) and high-density (HD) Setd7+/+
(closed bars) and Setd7/ (open bars) MEFs was
determined by qPCR. Expression is relative to
Setd7+/+ using actin as housekeeping gene.
(C and D) Yap localization in (C) low-density and
(D) high-density Setd7+/+ and Setd7/MEFs was
determined by immunofluorescent staining.
(E) Nuclear Yap was quantified for individual nuclei
of Setd7+/+ (closed circles) and Setd7/ (open
circles) MEFs. L, low-density cultures; H, high-
density cultures.
(F) Setd7/MEFs were transfected with plasmids
expressing either Set7 or methyltransferase-defi-
cient Set7H297G and expression of Ctgf and Yap
localization was determined.
(G) Setd7+/+ MEFs were transfected with plasmids
expressing either Set7 or methyltransferase-defi-
cient Set7H297G and expression of Ctgf and Yap
localization was determined. Data are mean ±
SEM and are representative of two to four inde-
pendent experiments.
AU, arbitrary units. *p < 0.05. See also Figure S2.
Developmental Cell
Yap Function Is Regulated by Lysine MethylationSetd7/MEFs at low or high density (Figure S2A). This suggests
that Set7 is required for downregulation of Yap-dependent
genes in contact-inhibited MEFs.
Yap activity is regulated by cytoplasmic retention and protea-
somal degradation, both of which are regulated by phosphoryla-
tion (Zhao et al., 2010; Zhao et al., 2007). In low-density cultures,
Yap was localized in the nucleus in both Setd7+/+ and Setd7/
MEFs (Figures 2C and 2E). Consistent with previous studies
(Schlegelmilch et al., 2011; Zhao et al., 2007), we observed
translocation of Yap to the cytosol and cytoplasmic membrane
in high-density cultures of Setd7+/+ MEFs (Figures 2D and 2E).
Strikingly, in high-density Setd7/ MEFs, Yap remained
primarily in the nucleus (Figures 2D and 2E), consistent with
the increased expression of Yap-dependent genes. Thus, these
results demonstrate that Set7 is required for the correct subcel-
lular localization of Yap following cell-cell contact.
Since KMTs can have methyltransferase-independent func-
tions (Lehnertz et al., 2010; Purcell et al., 2011), we next exam-
ined whether Yap regulation by Set7 was methyltransferase
dependent. We transfected Setd7+/+ and Setd7/ MEFs with
wild-type Set7 or a mutant form of Set7 with a point mutation
of residue 297 histidine to a glycine (Set7H297G) that has been
shown to inactivate the methyltransferase activity (Nishioka
et al., 2002; Tao et al., 2011), and we measured Ctgf expression
and nuclear Yap. In Setd7/ MEFs, we were able to recover
both Ctgf gene expression and loss of nuclear Yap (Figure 2F)
with Set7 but not Set7H297G, indicating that the methyltransfer-
ase activity of Set7 is required for the cytoplasmic retention of190 Developmental Cell 26, 188–194, July 29, 2013 ª2013 Elsevier InYap and subsequent regulation of target genes. As part of our
control experiments, we also transfected the plasmids into
Setd7+/+ MEFs. Strikingly, we found that Set7H297G acts as a
dominant negative, as the introduction of this construct in
Setd7+/+ MEFs resulted in increased Ctgf expression and
enhanced nuclear Yap (Figure 2G). Thus, the methyltransferase
activity of Set7 is a critical regulatory mechanism that controls
the Hippo pathway through the subcellular localization of Yap.
Following phosphorylation of Yap, two distinct processes—
cytoplasmic retention and ubiquitin-mediated degradation—are
initiated (Zhao et al., 2010). Although we did not detect cyto-
plasmic Yap in high-density Setd7/ MEFs by immunofluo-
rescence, we failed to observe a difference in the levels of
S127-phosphorylated Yap in Setd7+/+ and Setd7/ MEFs (Fig-
ure 3A), demonstrating that, in the absence of Set7, Yap can
exit the nucleus and be phosphorylated but that cytoplasmic
retention is impaired. We next tested if degradation of Yap was
impaired. To test this, we seeded equal numbers of Setd7+/+
and Setd7/ MEFs cells at low and high densities by varying
the size of the culture dish. Twenty-four hours later, we observed
similar density-induced degradation of Yap (Figure 3B), demon-
strating that the degradation pathway was not impaired in the
absenceof Set7. Furthermore,whenwe left high-density cultures
to overgrow for an additional 48 hr, we observed reduced total
Yap levels in Setd7/ MEFs compared to Setd7+/+ MEFs (Fig-
ure 3C), suggesting that cytoplasmic retention and not degrada-
tion was impaired in the absence of Set7. Consistent with this,
confocal microscopy of the overgrown (hyperconfluent) cellsc.
Yap
pYap
Gapdh
A
Gapdh
Yap
LD HD LD HD
B
Gapdh
Yap
C
CHX (h) 0 2 4 0 2 46 8 6 8
Setd7+/+ Setd7-/-
Gapdh
Yap
D
AP
I Y
AP
Setd7+/+ Setd7-/-D E
+/+ -/- +/+ -/-
+/+ -/-
Figure 3. Set7 Does Not Control Phosphor-
ylation or Degradation of Yap
(A) Setd7+/+ or Setd7/ MEFs were grown to
confluence, and whole cell extracts were im-
munoblotted with antibodies against Yap, pYap
S127, and Gapdh.
(B) Equal cell numbers were seeded in either a petri
dish or six-well plate and lysed 24 hr later. Density-
dependent Yap degradation was not affected by
lack of Set7.
(C and D) High-density seeded cells were over-
grown for an additional 48 hr (hyperconfluent), and
Yap was (C) quantified and (D) localized.
(E) Kinetics of Yap degradation was determined by
treating Setd7+/+ and Setd7/ MEFs with cyclo-
heximide (CHX) for indicated hours, followed by
immunoblotting of whole cell extracts with anti-
bodies against Yap and Gapdh. Results are
representative of more than three independent
experiments.
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Yap Function Is Regulated by Lysine Methylationrevealed that Yap accumulates in the cytoplasm/membrane of
Setd7+/+ MEFs, whereas the remaining Yap in Setd7/ MEFs
was primarily nuclear (Figure 3D). Finally, to test degradation ki-
netics, we incubated high-density Setd7+/+ and Setd7/ MEFs
in the presence of cycloheximide and followed Yap protein levels
over time. We did not observe differences in the degradation
kinetics of YapbetweenSetd7+/+ andSetd7/MEFs (Figure 3E).
Having a fully functional degradation pathway is the likely reason
Setd7/ mice are viable, and we do not observe a phenotype
similar to mice that overexpress Yap or YapS127A (Camargo
et al., 2007; Dong et al., 2007). Together, these results indicate
that Set7 is required for cytoplasmic retention, but not degrada-
tion, of Yap.
To determine how Set7 regulates Yap localization, we exam-
ined whether Set7 interacted with Yap. Coimmunoprecipitation
of native Yap from Setd7+/+ MEFs cultured at high density
demonstrated that Set7 was in a complex with Yap (Figure 4A),
but not with Tead1 (Figure S3A). Because Set7 does not have
a signal sequence to enter or leave the nucleus (Donlin et al.,
2012), we hypothesized that Set7-Yap interactions were occur-
ring in the cytoplasm. We found that Set7, like pYapS127, was
present primarily in the cytoplasm of high-density (confluent)
MEFs (Figure 4B), suggesting that Set7 binds Yap in the cyto-
plasm and that this is where Set7 likely acts to promote the cyto-
plasmic retention of Yap. When immunoprecipitated Yap was
analyzed by immunoblotting with two distinct anti-methyl lysine
antibodies (ab23366, recognizing both mono- and dimethylated
lysine, and ab7315, recognizing primarily dimethylated lysine) we
found that Yap wasmonomethylated in Setd7+/+ MEFs but not in
Setd7/ MEFs (Figure 4A). These results, combined with our
finding that Set7 forms complexes with Yap, suggested that
Set7 could directly monomethylate Yap.
Mass spectrometric analysis of Yap immunoprecipitated from
confluent HEK293 cells stably expressing a Flag-tagged version
of Yap was performed. Targeted high-resolution multiple reac-
tionmonitoring of the Yap 488-498 peptide revealed that a single
lysine residue (K494) is monomethylated (Figure 4C), consistent
with the monomethyltransferase activity of Set7 (Xiao et al.,
2003). Di- or trimethylation of Yap K494 could not be detected
(Table S1). To directly test whether K494was involved in the sub-Devecellular localization of Yap, we transfected Setd7+/+ MEFs with
Yap containing either a mutation of the methylation site
K494 (K494R) or the adjacent lysine residue K497 (K497R). Strik-
ingly, we observed increased Yap nuclear localization in MEFs
transfected with Yap K494R but not K497R (Figures 4D and
4E), despite normal S127 phosphorylation (Figure 4G). We
observed increased Ctgf expression in cells transfected with
the YapK494R mutant (Figure 4F). Although we cannot
unequivocally rule out other potential methylation sites in Yap,
our results indicate that monomethylation of Yap specifically at
K494 is required for Yap cytoplasmic retention and function.
In this study, we have identified several phenotypes in
Setd7/mice that suggest the involvement of Set7 in regulation
of the Hippo pathway. One observation from our studies is that
Set7 is a cytoplasmic protein in high-density grownMEFs, which
could explain the normal levels of H3K4me1 observed in
Setd7/ MEFs (Lehnertz et al., 2011). Unlike most KMTs, Set7
does not have a nuclear export signal or nuclear localization
signal (Donlin et al., 2012), and Set7 is the onlymethyltransferase
that contains membrane occupation and recognition nexus
repeats (Morn repeats) that are found in proteins linking the
membrane to the cytoskeleton (Garbino et al., 2009). It is
tempting to speculate that Set7 is located at cellular junctions
where it would methylate and sequester Yap from nuclear entry
and degradation. While phosphorylation of Yap by the upstream
Hippo pathway kinases Lats1/2 has been shown to regulate
cytoplasmic retention, our results demonstrate that Set7 is crit-
ical for the cytoplasmic sequestration of Yap through the mono-
methylation of K494. The molecular mechanisms of how Yap
methylation controls cytoplasmic sequestration are unknown.
The K494 methylation site in Yap is proximal to the carboxyl-
terminal PDZ-binding domain, and methylation of this site may
impinge upon Yap interactions with PDZ-dependent binding
partners including Zona occludens-2 (Oka et al., 2010) and Nherf
(Mohler et al., 1999). Furthermore, methylated Yap is a minority
of the total cellular Yap protein, suggesting that Yap methylation
is a dynamic process, and future studies to identify specific
demethylases potentially involved in Yap localization are war-
ranted. Finally, whether Hippo-pathway-dependent phosphory-
lation of Yap is required for Set7-dependent methylation remainslopmental Cell 26, 188–194, July 29, 2013 ª2013 Elsevier Inc. 191
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Figure 4. Set7 Monomethylates Yap on
Lysine 494, and Lysine 494 Is Required for
Cytoplasmic Retention
(A) Anti-Yap immunoprecipitates (IP) from high-
density Setd7+/+ and Setd7/ MEFs were im-
munoblotted for Yap, Set7, methyl-lysine (mono-,
dimethylated) (ab23366), and dimethyl-lysine
(ab7315). IB, immunoblots.
(B) Cytosolic and nuclear fractions were isolated
from high-density (confluent) cell cultures and
probed for Yap, pYap, Set7, and Histone H3.
(C) Tandem mass spectrometry spectrum of Glu-
C-digested Yap488-498 fragment (methylated
K494 [MH]+2, mass 594.8 Da). Detected product
ions are indicated in red (y ions) and blue (b ions).
(D) Setd7+/+ MEFs were transfected with indicated
Flag-Yap constructs, grown to confluence (unless
indicated), and stained with a Flag-specific anti-
body followed by a fluorescent secondary anti-
body and DAPI.
(E) Nuclear Flag fluorescence was quantified.
(F) Setd7+/+ MEFs were transfected with indicated
plasmids, and Ctgf expression was measured of
confluent cell cultures.
(G) HEK293 cells were transfected with indicated
constructs, anti-Flag was used for IP, and IPs
were immunoblotted using anti-Flag and anti-
pYapS127. Data are presented as mean ±
SEM and are representative of two to three
experiments.
au, arbitrary units. *p < 0.05. See also Figure S3
and Table S1.
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Yap Function Is Regulated by Lysine Methylationan open question. More generally, our finding that methylation is
an important mechanism for controlling cytoplasmic/nuclear
localization could have implications for other proteins that are
regulated by subcellular localization.
EXPERIMENTAL PROCEDURES
Mice
Villin-Cre mice were obtained from Jackson Laboratories. Setd7/ and
Setd7f/f mice were described previously (Lehnertz et al., 2011). We did not
observe any physiological effects from Cre expression. Animals were main-
tained in a specific-pathogen-free environment and tested negative for patho-
gens in routine screening. All experiments were carried out at the University of
British Columbia following institutional guidelines.
IEC Isolation
IECs were isolated as previously described (Zaph et al., 2007). Briefly, intes-
tines were opened lengthwise, washed in PBS containing penicillin and
streptomycin, and cut into 1 cm pieces. IECs were obtained by shaking
intestinal tissue in 2 mM EDTA in PBS for 20 min at 37C twice. IECs were
isolated, RNA was purified, and gene expression analyzed by quantitative
PCR (qPCR).
Tissue Staining
Large intestines were fixed in formalin and paraffin-embedded. Tissue sec-
tions were stained with hematoxylin and eosin (H&E). Slides were analyzed
on a Zeiss Axioplan2 microscope, and images were captured using a Qimag-
ing Retiga EX CCD camera and Openlab 4.0.4 software (PerkinElmer). For
immunofluorescence, 5 mm sections of paraformaldehyde-fixed, paraffin-
embedded tissues were incubated with anti-Yap (Cell Signaling) followed by
Alexa568-conjugated goat anti-rabbit and DAPI. Mice were injected with192 Developmental Cell 26, 188–194, July 29, 2013 ª2013 Elsevier InEdU 2 hr prior to sacrifice, and cecal sections were stained using Alexa568
Azide (Invitrogen) according to manufacturer instructions.
Cell Culture, Proliferation, and Transfection
MEFs were isolated and immortalized with SV40 as described previously (Leh-
nertz et al., 2011), and they were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal calf serum (FCS) and antibiotics,
detached using trypsin (0.25%), and seeded at appropriate densities. Cells
were counted after trypsin detachment using a hemocytometer. MEFs were
transfected with plasmids encoding Flag-Set7, Flag-Set7H297G (a point muta-
tion that abolishes Set7 methyltransferase activity) (Nishioka et al., 2002; Tao
et al., 2011), Flag-Yap, Flag-YapK494R, or Flag-YapK497R (Addgene ‘‘19045’’)
(Oka et al., 2008; Hata et al., 2012) constructs using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s descriptions.
Yap Localization
Cells were seeded at different densities on tissue-culture-treated plastic
chamber slides (ibidi GmbH) in DMEM + 10% FCS and incubated for 24 hr.
Cells were then fixed in 4% paraformaldehyde for 20 min, permeabilized in
0.5% Triton X in PBS for 3 min, and blocked in 3% bovine serum albumin
(BSA) in PBS for 20 min. Fixed cells were incubated with rabbit anti-Yap anti-
bodies (Cell Signaling) in 3% BSA in PBS at a dilution of 1:200 for 40 min,
washed five times for 5 min with PBS, and then incubated with secondary
Alexa 488/568-conjugated goat anti-rabbit antibodies at a dilution of 1:400
for 20 min. Cells were again washed five times for 5 min with PBS, and then
mounting media that contained DAPI (Invitrogen) was added before imaging
with a confocal microscope (Olympus FV1000).
Statistical Analysis
Results represent the mean ± SEM. Statistical significance was determined by
Student’s t test or one-way analysis of variance with subsequent post hoc test.c.
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